Fosamax Lawsuits Update: Rottenstein Law Group Responds to Femur Fracture Verdict in Merck’s Favor

The Rottenstein Law Group, which represents clients in Fosamax lawsuits, encourages those who seek to file lawsuits to continue to do so, despite the ruling in what was considered a bellwether trial for Fosamax femur fracture side effects. The firm maintains a Fosamax Lawsuit Information Center at http://www.rotlaw.com/fosamax-femur-fractures/, which has more information on trials and side effects and how to file a Fosamax lawsuit.

Trenton, N.J. (PRWEB) April 30, 2013

A New Jersey jury ruled in favor of pharmaceutical company Merck in a Fosamax femur fracture trial in Trenton on April 29.* The Rottenstein Law Group, which represents clients in Fosamax lawsuits, encourages those who seek to file lawsuits to continue to do so, despite the ruling in what was considered a bellwether trial for Fosamax femur fracture side effects. The firm maintains a Fosamax Lawsuit Information Center at http://www.rotlaw.com/fosamax-femur-fractures/, which has more information on trials and side effects and how to file a Fosamax lawsuit.

“Though the verdict did not favor the plaintiff, there is no reason for the Fosamax plaintiffs across the nation to be discouraged,” said Rochelle Rottenstein, principal of the Rottenstein Law Group.

Bernadette Glynn, 58, sued Merck, asserting that it knew Fosamax could cause femur fractures and brittle bones years before the drug went to market, according to Bloomberg. The jury found that Glynn’s injuries ruled out Fosamax as a cause. Instead, the jury ruled that Glynn’s femur fracture was consistent with a traumatic injury (Glynn v. Merck & Co., 3:11-cv-05304, U.S. District Court for the District of New Jersey).

New Jersey-based Merck faces more than 3,000 femur fracture lawsuits (in addition to more than 1,200 lawsuits over jawbone death claims), according to Bloomberg.

Fosamax, its generic equivalent and other similar bisphosphonate drugs are prescribed to treat osteoporosis. In 2010, according to Bloomberg, a study published in the Journal of Bone and Mineral Research found that the drug, approved in 1995, could be linked to an increase in femur fractures.

Nationwide Fosamax lawsuits were categorized into two different federal pretrial case consolidations for efficiency purposes. Cases involving alleged femur fractures are handled in the U.S. District Court for the District of New Jersey (MDL-2243). Lawsuits related to Fosamax’s alleged jaw death side effects are being handled in the U.S. District Court for the Southern District of New York (MDL-1789).

The Rottenstein Law Group encourages people to visit this page to download a free informational brochure on the drug’s side effects and how to file a lawsuit.

About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

*bloomberg.com/news/2013-04-29/merck-says-jury-rules-in-its-favor-in-fosamax-trial.html

Contact:
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
http://www.rotlaw.com

                            ###